June 15th, 2010 by admin
What three trends are most important to pharma these days? Generics, emerging markets and personalized medicine, according to the Harvard Business Review. Branded generics are the wave of Big Pharma’s future, HBR says. These branded versions of off-patent meds sell at higher prices than regular generics do, but are cheaper than the branded meds themselves. They give a measure of assurance to patients worried about counterfeit meds–and to those concerned that unbranded generics won’t work as well as their branded counterparts. They also offer drugmakers a niche in emerging countries.
Continue reading ‘Pharma Trifecta: Generics, New Markets and Personalization’
June 14th, 2010 by admin
First it was pharma iPhone apps for doctors. Now it’s iPads for pharma reps. Otsuka Pharmaceutical is loading up on the Apple gadgets, aiming to help its sales reps deliver the latest drug info to doctors. The first wave of 1,300 iPads will go to the company’s reps in Japan, but Otsuka is considering using the gadget all over the world.
Continue reading ‘Otsuka to Arm Sales Reps with 1,300 iPads’
March 18th, 2010 by admin
What qualifications are most important for pharma sales reps? You can forget business know-how; you can even overlook personal charm. The most important thing a sales rep needs to have is experience, says a new survey conducted by the Hay Group.
Continue reading ‘Hiring Reps is a Song of Experience’
January 5th, 2010 by admin
The full implications of Pfizer’s big R&D shakeup are just being felt worldwide lately. In that respect there is still no news on just how many of the 14,500 people working in research for Wyeth and Pfizer will be dismissed. However, the company has announced that these lay-offs will comprise a “considerable” section of the 15 percent job cuts being projected across the board. Overall, Pfizer is shuttering 35 percent of all its worldwide research and development space.
Continue reading ‘Pfizer Undertakes Major R&D Cutbacks’
